newwin
Luciann Nguyen
Settings
← Accounts
biotech

Shandong Suncadia Medicine Co., Ltd.

39
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

Shandong Suncadia Medicine Co., Ltd.

New trial — A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

New trialNCT06383871
39/100
Opportunity
Commercial fit0/25
Clinical timing20/20
Biomarker need0/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New phase 1 trial NCT06383871 posted by Shandong Suncadia Medicine Co., Ltd.: "A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour". New trial on a phase 1 recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 230 days ago.

ConfidenceHigh · 80%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT06383871
A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour
phase 1
—